Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening an effort to rein in drug costs. The new prices, which will take ...

President Donald Trump on Friday, Dec. 19, announced nine pharmaceutical companies have agreed to sell medications at lower prices, part of his administration's effort to lower drug prices to levels ...

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...